Correlating the Gut Microbiome to Health and Disease

The Gut-Brain Axis Dietary, Probiotic, and Prebiotic Interventions on the Microbiota

Volumn , Issue , 2016, Pages 261-291

  Marques, T M ^a   Holster, S ^a   Wall, R ^a   Konig J ^a   Brummer, R J ^a   de Vos, W M ^b,c  

^a Örebro University   (Sweden)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Gut microbiota; Immune system related diseases; Intestinal diseases; Metabolic diseases; Nervous system related diseases; Therapies for gut microbiota modulation

Indexed keywords

EID: 85011779736     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-802304-4.00012-8     Document Type: Chapter

References (180)

1. Abdollahi-Roodsaz S., Joosten L.A., Koenders M.I., Devesa I., Roelofs M.F., Radstake T.R., et al. Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J. Clin. Investig. 2008, 118(1):205.
2. Abbott R.D., Petrovitch H., White L.R., Masaki K.H., Tanner C.M., Curb J.D., et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001, 57(3):456-462.
3. Abrahamsson T.R., Jakobsson H.E., Andersson A.F., Björkstén B., Engstrand L., Jenmalm M.C. Low diversity of the gut microbiota in infants with atopic eczema. J. Allergy Clin. Immunol. 2012, 129(2):434-440.
4. Abrahamsson T.R., Jakobsson H.E., Andersson A.F., Björkstén B., Engstrand L., Jenmalm M.C. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin. Exp. Allergy 2014, 44(6):842-850.
5. Adams J.B., Johansen L.J., Powell L.D., Quig D., Rubin R.A. Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity. BMC Gastroenterology 2011, 11(1):22.
6. Aqel B., DiBaise J.K. Role of the gut microbiome in nonalcoholic fatty liver disease. Nutr. Clin. Pract. 2015, 10.1177/0884533615605811.
7. Armougom F., Henry M., Vialettes B., Raccah D., Raoult D. Monitoring bacterial community of human gut microbiota reveals an increase in Lactobacillus in obese patients and Methanogens in anorexic patients. PLoS One 2009, 4(9):e7125.
8. Arrieta M.C., Stiemsma L.T., Dimitriu P.A., Thorson L., Russell S., Yurist-Doutsch S., et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci. Transl. Med. 2015, 7(307):307ra152.
9. Atarashi K., Tanoue T., Ando M., Kamada N., Nagano Y., Narushima S., et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 2015, 163(2):367-380.
10. Bäckhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(44):15718-15723.
11. Bäckhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307(5717):1915-1920.
12. Belzer C., de Vos W.M. Microbes inside-from diversity to function: the case of Akkermansia. ISME J. 2012, 6(8):1449-1458.
13. Benton D., Williams C., Brown A. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur. J. Clin. Nutr. 2007, 61(3):355-361.
14. Bercik P., Denou E., Collins J., Jackson W., Lu J., Jury J., et al. The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 2011, 141(2):599-609.
15. Berer K., Mues M., Koutrolos M., Al Rasbi Z., Boziki M., Johner C., et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011, 479(7374):538-541.
16. Bisgaard H., Li N., Bonnelykke K., Chawes B.L.K., Skov T., Paludan-Müller G., et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J. Allergy Clin. Immunol. 2011, 128(3):646-652.
17. Borges C.M. Role of colonic microbiota in colorectal carcinogenesis: a systematic review. Rev. Esp. Enferm. Dig. 2015, 107.
18. Bravo J.A., Forsythe P., Chew M.V., Escaravage E., Savignac H.M., Dinan T.G., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(38):16050-16055.
19. Brown C.T., Davis-Richardson A.G., Giongo A., Gano K.A., Crabb D.B., Mukherjee N., et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 2011, 6(10):e25792.
20. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56(7):1761-1772.
21. Cebra J.J., Periwal S.B., Lee G., Lee F., Shroff K.E. Development and maintenance of the gut-associated lymphoid tissue (GALT): the roles of enteric bacteria and viruses. J. Immunol. Res. 1998, 6(1-2):13-18.
22. Claesson M.J., Jeffery I.B., Conde S., Power S.E., O'Connor E.M., Cusack S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012, 488(7410):178-184.
23. Collins S.M., Kassam Z., Bercik P. The adoptive transfer of behavioral phenotype via the intestinal microbiota: experimental evidence and clinical implications. Curr. Opin. Microbiol. 2013, 16(3):240-245.
24. Cotillard A., Kennedy S.P., Kong L.C., Prifti P., Pons F., et al. Dietary intervention impact on gut microbial gene richness. Nature 2013, 500:585-588.
25. Di Cagno R., De Angelis M., De Pasquale I., Ndagijimana M., Vernocchi P., Ricciuti P., et al. Duodenal and faecal microbiota of celiac children: molecular, phenotype and metabolome characterization. BMC Microbiol. 2011, 11(1):219.
26. Dobell C. Anthony Van Leeuwenhoek and His Little Animals 1932, Harcourt Brace & Company, New York.
27. Duncan S.H., Lobley G.E., Holtrop G., Ince J., Johnstone A.M., Louis P., Flint H.J. Human colonic microbiota associated with diet, obesity and weight loss. Int. J. Obes. 2008, 32(11):1720-1724.
28. Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., et al. Diversity of the human intestinal microbial flora. Science 2005, 308(5728):1635-1638.
29. Ege M.J., Mayer M., Normand A.C., Genuneit J., Cookson W.O., Braun-Fahrländer C., et al. Exposure to environmental microorganisms and childhood asthma. N. Engl. J. Med. 2011, 364(8):701-709.
30. Everard A., Belzer C., Geurts L., Ouwerkerk J.P., Druart C., Bindels L.B., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. U.S.A. 2013, 110(22):9066-9071.
31. Eriguchi Y., Nakamura K., Hashimoto D., Shimoda S., Shimono N., Akashi K., et al. Decreased secretion of Paneth cell α-defensins in graft-versus-host disease. Transpl. Infect. Dis. 2015, 17(5):702-706.
32. Festi D., Schiumerini R., Eusebi L.H., Marasco G., Taddia M., Colecchia A. Gut microbiota and metabolic syndrome. World J. Gastroenterol. 2014, 20(43):16079.
33. Fischer H., Holst E., Karlsson F., Benoni C., Toth E., Olesen M., et al. Altered microbiota in microscopic colitis. Gut 2015, 10.1136/gutjnl-2014-308956.
34. Forno E., Onderdonk A.B., McCracken J., Litonjua A.A., Laskey D., Delaney M.L., et al. Diversity of the gut microbiota and eczema in early life. Clin. Mol. Allergy 2008, 6(11):11.
35. Forsyth C.B., Shannon K.M., Kordower J.H., Voigt R.M., Shaikh M., Jaglin J.A., et al. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PLoS One 2011, 6(12):e28032.
36. Frémont M., Coomans D., Massart S., De Meirleir K. High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients. Anaerobe 2013, 22:50-56.
37. Fuentes S., van Nood E., Tims S., Heikamp-de Jong I., Ter Braak C.J., Keller J.J., et al. Reset of a critically disturbed microbial ecosystem: faecal transplant in recurrent Clostridium difficile infection. ISME J. 2014, 8(8):1621-1633.
38. Fujimura K.E., Lynch S.V. Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microb. 2015, 17(5):592-602.
39. Galley J.D., Bailey M., Dush C.K., Schoppe-Sullivan S., Christian L.M. Maternal obesity is associated with alterations in the gut microbiome in toddlers. PLoS One 2014, 9(11):e113026.
40. Gao Z., Yin J., Zhang J., Ward R.E., Martin R.J., Lefevre M., Cefalu W.T., Ye J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 2009, 58(7):1509-1517.
41. Ge H., Li X., Weiszmann J., Wang P., Baribault H., Chen J.L., et al. Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology 2008, 149(9):4519-4526.
42. Giacomin P., Zakrzewski M., Croese J., Su X., Sotillo J., McCann L., et al. Experimental hookworm infection and escalating gluten challenges are associated with increased microbial richness in celiac subjects. Sci. Rep. 2015, 5. 10.1038/srep13797.
43. Gibson M.K., Crofts T.S., Dantas G. Antibiotics and the developing infant gut microbiota and resistome. Curr. Opin. Microbiol. 2015, 27:51-56.
44. Giongo A., Gano K.A., Crabb D.B., Mukherjee N., Novelo L.L., Casella G., et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 2011, 5(1):82-91.
45. Grölund M.M., Lehtonen O.P., Eerola E., Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery. J. Pediatr. Gastroenterol. Nutr. 1999, 28(1):19-25.
46. Harach T., Marungruang N., Dutilleul N., Cheatham V., Mc Coy K.D., Neher J.J., Jucker M., Fåk F., Lasser T., Bolmont T. Reduction of Alzheimer's Disease Beta-amyloid Pathology in the Absence of Gut Microbiota 2015, (access 31.10.15.). http://arxiv.org/ftp/arxiv/papers/1509/1509.02273.pdf.
47. Heijtz R.D., Wang S., Anuar F., Qian Y., Björkholm B., Samuelsson A., et al. Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(7):3047-3052.
48. Henao-Mejia J., Elinav E., Jin C., Hao L., Mehal W.Z., Strowig T., Flavell R.A. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482(7384):179-185.
49. Hong Y.H., Nishimura Y., Hishikawa D., Tsuzuki H., Miyahara H., Gotoh C., et al. Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43. Endocrinology 2005, 146(12):5092-5099.
50. Hooper L.V., Bry L., Falk P.G., Gordon J.I. Host-microbial symbiosis in the mammalian intestine: exploring an internal ecosystem. Bioessays 1998, 20(4):336-343.
51. Hooper L.V., Littman D.R., Macpherson A.J. Interactions between the microbiota and the immune system. Science 2012, 336(6086):1268-1273.
52. Horvath K., Papadimitriou J.C., Rabsztyn A., Drachenberg C., Tildon J.T. Gastrointestinal abnormalities in children with autistic disorder. J. Pediatr. 1999, 135(5):559-563.
53. Hoveyda N., Heneghan C., Mahtani K.R., Perera R., Roberts N., Glasziou P. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol. 2009, 9(1):15.
54. Hu H.J., Park S.G., Jang H.B., Choi M.K., Park K.H., Kang J.H., et al. Obesity alters the microbial community profile in Korean adolescents. PLoS One 2015, 10(7):e0134333.
55. Ivanov I.I., de Llanos Frutos R., Manel N., Yoshinaga K., Rifkin D.B., Sartor R.B., et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microb. 2008, 4(4):337-349.
56. Jayashree B., Bibin Y.S., Prabhu D., Shanthirani C.S., Gokulakrishnan K., Lakshmi B.S., et al. Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol. Cell. Biochem. 2014, 388(1-2):203-210.
57. Jiang W., Wu N., Wang X., Chi Y., Zhang Y., Qiu X., et al. Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease. Sci. Rep. 2015, 5. 10.1038/srep08096.
58. Kalliomäki M., Satokari R., Lähteenoja H., Vähämiko S., Grönlund J., Routi T., Salminen S. Expression of microbiota, Toll-like receptors, and their regulators in the small intestinal mucosa in celiac disease. J. Pediatr. Gastroenterol. Nutr. 2012, 54(6):727-732.
59. Kamada N., Seo S.U., Chen G.Y., Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 2013, 13(5):321-335.
60. Kane M., Case L.K., Kopaskie K., Kozlova A., MacDearmid C., Chervonsky A.V., Golovkina T.V. Successful transmission of a retrovirus depends on the commensal microbiota. Science 2011, 334(6053):245-249.
61. Karaki S.I., Tazoe H., Hayashi H., Kashiwabara H., Tooyama K., Suzuki Y., Kuwahara A. Expression of the short-chain fatty acid receptor, GPR43, in the human colon. J. Mol. Histol. 2008, 39(2):135-142.
62. Karlsson F.H., Tremaroli V., Nookaew I., Bergström G., Behre C.J., Fagerberg B., et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 2013, 498(7452):99-103.
63. Karri S., Martinez V.A., Coimbatore G. Effect of dihydrotestosterone on gastrointestinal tract of male Alzheimer's disease transgenic mice. Indian J. Exp. Biol. 2010, 48(5):453-465.
64. Kasai C., Sugimoto K., Moritani I., Tanaka J., Oya Y., Inoue H., et al. Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing. BMC Gastroenterol. 2015, 15(1):100.
65. Keku T.O., Dulal S., Deveaux A., Jovov B., Han X. The gastrointestinal microbiota and colorectal cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 2015, 308(5):G351-G363.
66. Kennedy P.J., Cryan J.F., Dinan T.G., Clarke G. Irritable bowel syndrome: a microbiome-gut-brain axis disorder?. World J. Gastroenterol. 2014, 20(39):14105.
67. Khoruts A., Dicksved J., Jansson J.K., Sadowsky M.J. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J. Clin. Gastroenterol. 2010, 44(5):354-360.
68. Kimura I., Ozawa K., Inoue D., Imamura T., Kimura K., Maeda T., Tsujimoto G. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat. Commun. 2013, 4:1829.
69. Koeth R.A., Wang Z., Levison B.S., Buffa J.A., Sheehy B.T., Britt E.B., et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 2013, 19(5):576-585.
70. Kolmeder C.A., Ritari J., Verdam F.J., Muth T., Keskitalo S., Varjosalo M., et al. Colonic metaproteomic signatures of active bacteria and the host in obesity. Proteomics 2015, 15(20):3544-3552.
71. König J., Brummer R.J. Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. Benefic. Microb. 2014, 5(3):247-261.
72. König J., Ganda-Mall J.P., Rangel I., Edebol-Carlman H., Brummer R.J. The role of the gut microbiota in brain function. Probiotics and Prebiotics: Current Research and Future Trends 2015, Caister Academic Press, Poole, UK. K. Venema, A.P. do Carmo (Eds.).
73. Koren O., Spor A., Felin J., Fåk F., Stombaugh J., Tremaroli V., et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(Suppl. 1):4592-4598.
74. Korpela K., Salonen A., Virta L.J., Kekkonen R.A., Forslund K., Bork P., de Vos W.M. Intestinal microbiome is related to lifetime antibiotic use in Finnish pre-school children. Nat. Commun. 2016, 7:10410. http://dx.doi.org/10.1038/ncomms10410.
75. Kostic A.D., Gevers D., Siljander H., Vatanen T., Hyötyläinen T., Hämäläinen A.M., et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microb. 2015, 17(2):260-273.
76. Kuss S.K., Best G.T., Etheredge C.A., Pruijssers A.J., Frierson J.M., Hooper L.V., et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 2011, 334(6053):249-252.
77. Lam V., Su J., Koprowski S., Hsu A., Tweddell J.S., Rafiee P., et al. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J. 2012, 26(4):1727-1735.
78. Larsen N., Vogensen F.K., Van Den Berg F.W., Nielsen D.S., Andreasen A.S., Pedersen B.K., et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010, 5(2):e9085.
79. Lathrop S.K., Bloom S.M., Rao S.M., Nutsch K., Lio C.W., Santacruz N., et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 2011, 478(7368):250-254.
80. Le Chatelier E., Nielsen T., Qin J., Prifti E., Hildebrand F., Falony G., et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013, 500(7464):541-546.
81. Lee H., Ko G. Effect of metformin on metabolic improvement and gut microbiota. Appl. Environ. Microbiol. 2014, 80(19):5935-5943.
82. Lee J.W., Lee Y.K., Yuk D.Y., Choi D.Y., Ban S.B., Oh K.W., Hong J.T. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J. Neuroinflammation 2008, 5(1):37.
83. Lepage P., Häsler R., Spehlmann M.E., Rehman A., Zvirbliene A., Begun A., et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 2011, 141(1):227-236.
84. Ley R.E., Bäckhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(31):11070-11075.
85. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444(7122):1022-1023.
86. Li J., Jia H., Cai X., Zhong H., Feng Q., Sunagawa S., et al. An integrated catalog of reference genes in the human gut microbiome. Nat. Biotechnol. 2014, 32(8):834-841.
87. Lopez-Siles M., Khan T.M., Duncan S.H., Harmsen H.J., Garcia-Gil L.J., Flint H.J. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Appl. Environ. Microbiol. 2012, 78(2):420-428.
88. Lynch S.V., Wood R.A., Boushey H., Bacharier L.B., Bloomberg G.R., Kattan M., et al. Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children. J. Allergy Clin. Immunol. 2014, 134(3):593-601.
89. Malinen E., Krogius-Kurikka L., Lyra A., Nikkilä J., Jääskeläinen A., Rinttilä T., et al. Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J. Gastroenterol. 2010, 16(36):4532.
90. Mattila E., Uusitalo-Seppälä R., Wuorela M., Lehtola L., Nurmi H., Ristikankare M., et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 2012, 142(3):490-496.
91. McNulty N.P., Yatsunenko T., Hsiao A., Faith J.J., Muegge B.D., Goodman A.L., et al. The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci. Transl. Med. 2011, 3(106):106ra106.
92. Membrez M., Blancher F., Jaquet M., et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 2008, 22:2416-2426.
93. Menees S.B., Maneerattannaporn M., Kim H.M., Chey W.D. The efficacy and safety of rifaximin for the irritable bowel syndrome: a systematic review and meta-analysis. Am. J. Gastroenterol. 2012, 107(1):28-35.
94. Messaoudi M., Lalonde R., Violle N., Javelot H., Desor D., Nejdi A., et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br. J. Nutr. 2011, 105(05):755-764.
95. Metchnikoff E., Mitchell P.C. The Prolongation of Life: Optimistic Studies 1907, W. Heinemann, London, (GP Putnam's Sons, New York).
96. Miele L., Valenza V., La Torre G., Montalto M., Cammarota G., Ricci R., et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009, 49(6):1877-1887.
97. Miyake S., Kim S., Suda W., Oshima K., Nakamura M., Matsuoka T., et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters. PLoS One 2015, 10(9):e0137429.
98. Moayyedi P., Surette M.G., Kim P.T., Libertucci J., Wolfe M., Onischi C., et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 2015, 149(1):102-109.e6.
99. Murphy S., Nguyen V.H. Role of gut microbiota in graft-versus-host disease. Leuk. Lymphoma 2011, 52(10):1844-1856.
100. Neish A.S. Microbes in gastrointestinal health and disease. Gastroenterology 2009, 136(1):65-80.
101. Neufeld K.M., Kang N., Bienenstock J., Foster J.A. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol. Motil. 2011, 23 (3), 255-264, e119.
102. Nistal E., Caminero A., Herrán A.R., Arias L., Vivas S., de Morales J.M.R., et al. Differences of small intestinal bacteria populations in adults and children with/without celiac disease: effect of age, gluten diet, and disease. Inflamm. Bowel Dis. 2012, 18(4):649-656.
103. van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E.G., de Vos W.M., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N. Engl. J. Med. 2013, 368(5):407-415.
104. O'Hara A.M., Shanahan F. The gut flora as a forgotten organ. EMBO Rep. 2006, 7(7):688-693.
105. Orrhage K., Nord C.E. Factors controlling the bacterial colonization of the intestine in breastfed infants. Acta Paediatr. 1999, 88(s430):47-57.
106. Ott S.J., Musfeldt M., Wenderoth D.F., Hampe J., Brant O., Fölsch U.R., et al. Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease. Gut 2004, 53(5):685-693.
107. Ownby D.R., Johnson C.C., Peterson E.L. Exposure to dogs and cats in the first year of life and risk of allergic sensitization at 6 to 7years of age. Jama 2002, 288(8):963-972.
108. Patterson E., Marques T.M., O'Sullivan O., Fitzgerald P., Fitzgerald G.F., Cotter P.D., et al. Streptozotocin-induced type-1-diabetes disease onset in Sprague-Dawley rats is associated with an altered intestinal microbiota composition and decreased diversity. Microbiology 2015, 161(Pt 1):182-193.
109. Petrof E.O., Gloor G.B., Vanner S.J., Weese S.J., Carter D., Daigneault M.C., et al. Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut. Microbiome 2013, 1(1):1-12.
110. Parnell J.A., Relmer R.A. Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am. J. Clin. Nutr. 2009, 89(6):1751-1759.
111. Psichias A., Sleeth M.L., Murphy K.G., Brook L., Bewick G.A., Hanyaloglu A.C., et al. The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Intl. J. Obes. (London) 2015, 39(3):424-429.
112. Pimentel M., Lembo A., Chey W.D., Zakko S., Ringel Y., Yu J., et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N. Engl. J. Med. 2011, 364(1):22-32.
113. Png C.W., Lindén S.K., Gilshenan K.S., Zoetendal E.G., McSweeney C.S., Sly L.I., et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 2010, 105(11):2420-2428.
114. Pozuelo M., Panda S., Santiago A., Mendez S., Accarino A., Santos J., et al. Reduction of butyrate- and methane-producing microorganisms in patients with irritable bowel syndrome. Sci. Rep. 2015, 5.
115. Qin J., Li Y., Cai Z., Li S., Zhu J., Zhang F., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490(7418):55-60.
116. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55(5):453-462.
117. Rajilić-Stojanović M., Biagi E., Heilig H.G., Kajander K., Kekkonen R.A., Tims S., de Vos W.M. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 2011, 141(5):1792-1801.
118. Rajilić-Stojanović M., Heilig H.G., Tims S., Zoetendal E.G., Vos W.M. Long-term monitoring of the human intestinal microbiota composition. Environ. Microbiol. 2012, 15(4):1146-1159.
119. Rajilić-Stojanović M., Shanahan F., Guarner F., de Vos W.M. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm. Bowel Dis. 2013, 19(3):481-488.
120. Ramirez-Farias C., Slezak K., Fuller Z., Duncan A., Holtrop G., Louis P. Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br. J. Nutr. 2009, 101(4):541-550.
121. Reichenberg A., Yirmiya R., Schuld A., Kraus T., Haack M., Morag A., Pollmächer T. Cytokine-associated emotional and cognitive disturbances in humans. Arch. Gen. Psychiatry 2001, 58(5):445-452.
122. Reunanen J., Kainulainen V., Huuskonen L., Ottman N., Belzer C., Huhtinen H., et al. Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer. Appl. Environ. Microbiol. 2015, 81(11):3655-3662.
123. Rivas M.N., Burton O.T., Wise P., Zhang Y.Q., Hobson S.A., Lloret M.G., et al. A microbiota signature associated with experimental food allergy promotes allergic sensitization and anaphylaxis. J. Allergy Clin. Immunol. 2013, 131(1):201-212.
124. Roos S., Dicksved J., Tarasco V., Locatelli E., Ricceri F., Grandin U., Savino F. 454 pyrosequencing analysis on faecal samples from a randomized DBPC trial of colicky infants treated with Lactobacillus reuteri DSM 17938. PLoS One 2013, 8(2):e56710.
125. Rossen N.G., Fuentes S., van der Spek M.J., Tijssen J., Hartman J.H., Duflou A., et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 2015, 149(1):110-118.e4.
126. Russell S.L., Gold M.J., Hartmann M., Willing B.P., Thorson L., Wlodarska M., et al. Early life antibiotic-driven changes in microbiota enhance susceptibility to allergic asthma. EMBO Rep. 2012, 13(5):440-447.
127. Samuel B.S., Shaito A., Motoike T., Rey F.E., Backhed F., Manchester J.K., et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(43):16767-16772.
128. Sanders M.E., Guarner F., Guerrant R., Holt P.R., Quigley E.M., Sartor R.B., et al. An update on the use and investigation of probiotics in health and disease. Gut 2013, 62(5):787-796.
129. Sandler R.H., Finegold S.M., Bolte E.R., Buchanan C.P., Maxwell A.P., Väisänen M.L., et al. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J. Child Neurol. 2000, 15(7):429-435.
130. Saulnier D.M., Riehle K., Mistretta T.A., Diaz M.A., Mandal D., Raza S., et al. Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome. Gastroenterology 2011, 141(5):1782-1791.
131. Sato J., Kanazawa A., Ikeda F., Yoshihara T., Goto H., Abe H., et al. Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes. Diabet. Care 2014, 37(8):2343-2350.
132. Scharlau D., Borowicki A., Habermann N., Hofmann T., Klenow S., Miene C., et al. Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat. Res. 2009, 682(1):39-53.
133. Scheperjans F., Aho V., Pereira P.A., Koskinen K., Paulin L., Pekkonen E., et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov. Disord. 2015, 30(3):350-358.
134. Scher J.U., Abramson S.B. The microbiome and rheumatoid arthritis. Nat. Rev. Rheumatol. 2011, 7(10):569-578.
135. Scher J.U., Sczesnak A., Longman R.S., Segata N., Ubeda C., Bielski C., et al. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2013, 2:e01202.
136. Schwiertz A., Taras D., Schäfer K., Beijer S., Bos N.A., Donus C., Hardt P.D. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010, 18(1):190-195.
137. Sheedy J.R., Wettenhall R.E., Scanlon D., Gooley P.R., Lewis D.P., Mcgregor N., et al. Increased d-lactic acid intestinal bacteria in patients with chronic fatigue syndrome. In Vivo 2009, 23(4):621-628.
138. Shin N., Lee J.W., Lee B., Kim M.S., Wong T.B., et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 2014, 63:727-735.
139. reg cell homeostasis. Science 2013, 341(6145):569-573.
140. Smits L.P., Bouter K.E., de Vos W.M., Borody T.J., Nieuwdorp M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 2013, 145(5):946-953.
141. Sobhani I., Tap J., Roudot-Thoraval F., Roperch J.P., Letulle S., Langella P., et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011, 6(1):e16393.
142. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermúdez-Humarán L.G., Gratadoux J.J., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(43):16731-16736.
143. Sokol H., Seksik P., Furet J., Firmesse O., Nion-Larmurier I., Beaugerie L., et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm. Bowel Dis. 2009, 15(8):1183-1189.
144. Spencer M.D., Hamp T.J., Reid R.W., Fischer L.M., Zeisel S.H., Fodor A.A. Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency. Gastroenterology 2011, 140(3):976-986.
145. Storrø O., Øien T., Langsrud Ø., Rudi K., Dotterud C., Johnsen R. Temporal variations in early gut microbial colonization are associated with allergen-specific immunoglobulin E but not atopic eczema at 2years of age. Clin. Exp. Allergy 2011, 41(11):1545-1554.
146. Strauss J., Kaplan G.G., Beck P.L., Rioux K., Panaccione R., DeVinney R., et al. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm. Bowel Dis. 2011, 17(9):1971-1978.
147. Strugnell R.A., Wijburg O.L. The role of secretory antibodies in infection immunity. Nat. Rev. Microbiol. 2010, 8(9):656-667.
148. Sundin J., Rangel I., Fuentes S., Heikamp-de Jong I., Hultgren-Hörnquist E., Vos W.M., Brummer R.J. Altered faecal and mucosal microbial composition in post-infectious irritable bowel syndrome patients correlates with mucosal lymphocyte phenotypes and psychological distress. Aliment. Pharmacol. Therap. 2015, 41(4):342-351.
149. Sundin J., Rangel I., Repsilber D., Brummer R.J. Cytokine response after stimulation with key commensal bacteria differ in post-infectious irritable bowel syndrome (PI-IBS) patients compared to healthy subjects. PloS One 2015, 10(9):e0134836.
150. Tana C., Umesaki Y., Imaoka A., Handa T., Kanazawa M., Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol. Motil. 2010, 22 (5), 512-519, e115.
151. Tims S., Derom C., Jonkers D.M., Vlietinck R., Saris W.H., Kleerebezem M., et al. Microbiota conservation and BMI signatures in adult monozygotic twins. ISME J. 2013, 7(4):707-717.
152. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444(7122):1027-1131.
153. Turnbaugh P.J., Hamady M., Yatsunenko T., Cantarel B.L., Duncan A., Ley R.E., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457(7228):480-484.
154. van Tongeren S.P., Slaets J.P., Harmsen H.J.M., Welling G.W. Fecal microbiota composition and frailty. Appl. Environ. Microbiol. 2005, 71(10):6438-6442.
155. Udina M., Castellví P., Moreno-España J., Navinés R., Valdés M., Forns X., et al. Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis. J. Clin. Psychiatry 2012, 73(8):1128-1138.
156. de Vos W.M. Fame and future of faecal transplantations-developing next-generation therapies with synthetic microbiomes. Microb. Biotechnol. 2013, 6(4):316-325.
157. de Vos W.M., de Vos E.A. Role of the intestinal microbiome in health and disease: from correlation to causation. Nutr. Rev. 2012, 70(Suppl. 1):S45-S56.
158. Verdam F.J., Fuentes S., de Jonge C., Zoetendal E.G., Erbil R., Greve J.W., et al. Human intestinal microbiota composition is associated with local and systemic inflammation in obesity. Obesity 2013, 21(12):E607-E615.
159. Vossen J.M., Guiot H.F., Lankester A.C., Vossen A.C., Bredius R.G., Wolterbeek R., et al. Complete suppression of the gut microbiome prevents acute graft-versus-host disease following allogeneic bone marrow transplantation. PLoS One 2014, 9(9):e105706.
160. Vrieze A., Van Nood E., Holleman F., Salojärvi J., Kootte R.S., Bartelsman J.F., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012, 143(4):913-916.
161. de Weerth C., Fuentes S., Puylaert P., de Vos W.M. Intestinal microbiota of infants with colic: development and specific signatures. Pediatrics 2013, 131(2):e550-e558.
162. Wang L., Christophersen C.T., Sorich M.J., Gerber J.P., Angley M.T., Conlon M.A. Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism. Appl. Environ. Microbiol. 2011, 77(18):6718-6721.
163. Wang M., Karlsson C., Olsson C., Adlerberth I., Wold A.E., Strachan D.P., et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J. Allergy Clin. Immunol. 2008, 121(1):129-134.
164. Wang T., Cai G., Qiu Y., Fei N., Zhang M., Pang X., et al. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2012, 6(2):320-329.
165. Wang Z., Klipfell E., Bennett B.J., Koeth R., Levison B.S., DuGar B., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011, 472(7341):57-63.
166. West C.E., Jenmalm M.C., Prescott S.L. The gut microbiota and its role in the development of allergic disease: a wider perspective. Clin. Exp. Allergy 2015, 45(1):43-53.
167. Williams B.L., Hornig M., Buie T., Bauman M.L., Cho Paik M., Wick I., et al. Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances. PLoS One 2011, 6(9):e24585.
168. Williams B.L., Hornig M., Parekh T., Lipkin W.I. Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio 2012, 3(1):e00261-11.
169. Willing B.P., Dicksved J., Halfvarson J., Andersson A.F., Lucio M., Zheng Z., et al. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010, 139(6):1844-1854.
170. Wu H.J., Ivanov I.I., Darce J., Hattori K., Shima T., Umesaki Y., et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32(6):815-827.
171. Xia Q., Grant S.F. The genetics of human obesity. Ann. N.Y. Acad. Sci. 2013, 1281(1):178-190.
172. Xiao L., Feng Q., Liang S., Sonne S.B., Xia Z., Qiu X., et al. A catalog of the mouse gut metagenome. Nat. Biotechnol. 2015, 33(10):1103-1108.
173. Yamashita T., Kasahara K., Emoto T., Matsumoto T., Mizoguchi T., Kitano N., et al. Intestinal immunity and gut microbiota as therapeutic targets for preventing atherosclerotic cardiovascular diseases. Circ. J. 2015, 79(9):1882-1890.
174. Yu J., Feng Q., Wong S.H., Zhang D., yi Liang Q., Qin Y., et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut 2015, 10.1136/gutjnl-2015-309800.
175. Zeller G., Tap J., Voigt A.Y., Sunagawa S., Kultima J.R., Costea P.I., et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol. Syst. Biol. 2014, 10(11):766.
176. Zhang R., Miller R.G., Gascon R., Champion S., Katz J., Lancero M., et al. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J. Neuroimmunol. 2009, 206(1):121-124.
177. Zhang X., Zhang D., Jia H., Feng Q., Wang D., Liang D., et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat. Med. 2015, 21:895-905.
178. Zhu L., Baker S.S., Gill C., Liu W., Alkhouri R., Baker R.D., Gill S.R. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 2013, 57(2):601-609.
179. Zoetendal E.G., Rajilić-Stojanović M., De Vos W.M. High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008, 57(11):1605-1615.
180. Zoetendal E.G., de Vos W.M. Effect of diet on the intestinal microbiota and its activity. Curr. Opin. Gastroenterol. 2014, 30(2):189-195.